Tower Research Capital (TRC)’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,323
| Closed | -$44K | – | 6434 |
|
|
2023
Q1 | $44K | Sell |
17,323
-496
| -3% | -$1.26K | ﹤0.01% | 2624 |
|
|
2022
Q4 | $27K | Buy |
17,819
+7,587
| +74% | +$11.5K | ﹤0.01% | 2857 |
|
|
2022
Q3 | $18K | Buy |
+10,232
| New | +$18K | ﹤0.01% | 4039 |
|
|
2022
Q2 | – | Sell |
-1,316
| Closed | -$3K | – | 6689 |
|
|
2022
Q1 | $3K | Buy |
+1,316
| New | +$3K | ﹤0.01% | 5447 |
|
|
2021
Q4 | – | Sell |
-2,276
| Closed | -$19K | – | 6706 |
|
|
2021
Q3 | $19K | Buy |
2,276
+2,057
| +939% | +$17.2K | ﹤0.01% | 3783 |
|
|
2021
Q2 | $2K | Sell |
219
-1,653
| -88% | -$15.1K | ﹤0.01% | 5095 |
|
|
2021
Q1 | $17K | Buy |
1,872
+126
| +7% | +$1.14K | ﹤0.01% | 4024 |
|
|
2020
Q4 | $18K | Sell |
1,746
-6,732
| -79% | -$69.4K | ﹤0.01% | 3946 |
|
|
2020
Q3 | $77K | Buy |
8,478
+7,063
| +499% | +$64.1K | ﹤0.01% | 3334 |
|
|
2020
Q2 | $10K | Buy |
1,415
+1,315
| +1,315% | +$9.29K | ﹤0.01% | 4027 |
|
|
2020
Q1 | $1K | Sell |
100
-2,020
| -95% | -$20.2K | ﹤0.01% | 2879 |
|
|
2019
Q4 | $28K | Buy |
+2,120
| New | +$28K | ﹤0.01% | 1719 |
|